国产在线一区二区三区AV,国产AV天堂无码一区二区三区,黄色电影免费观看,国内精品久久久久久99蜜桃

Stock(600222)Hot line:010-61006450

MAH

Leader of "0" Cost MAH 3.0 Era

Platform Overview

Platform Overview
————???????—???????—???????—???????—???????—???????—

 
The project Initiation service platform has more than 20 professional knowledge personnel, all from Shenyang Pharmaceutical University, Chinese Academy of Medical Sciences, Peking Union Medical College and other well-known universities at home and abroad, and has set up generic drug project strategy center, clinical & pharmacology center, intellectual property center, big data analysis center, international new product strategy center, based on the all-round analysis of the pharmaceutical industry and combined with the company's own differentiated positioning, can provide customers with personalized information technology services and comprehensive information assurance.

 Service Content

—???????—???????—???????—???????—???????—???????—???????—???????—???????—

1) Generic Drug Project Initiation: Project development risk assessment is carried out through comprehensive analysis of listed product information, including review overview, patents, market prospects, competition pattern, technical barriers, policy dynamics and other mainstream regulatory countries in Europe, the United States, Japan, China, Canada, Australia and other mainstream regulatory countries.
???????

2)Improvement and Innovation Projects: According to the domestic clinical needs and the guidance of policies and regulations, look for potential improvement and innovation projects, conduct comprehensive research from the aspects of product clinical positioning, market value, competition dynamics, patent layout, and development and listing paths of such projects at home and abroad, determine the adequacy and feasibility of the basis for the topic, and conduct in-depth pharmaceutical technology evaluation, clinical evaluation, development cycle and cost evaluation of the proposed development project.
 

3) Strategy Consulting Service: According to the needs of enterprises, provide partners with product pipeline sustainable development planning, feasibility analysis of new entry fields, and R&D strategy formulation after policy changes, such as the development opportunities and challenges in the cardiovascular field, the key points of improved new drug technology research and development, the analysis of the clinical drug competition pattern of platforms (ophthalmic preparations, enteric-coatedpreparations, sustained-release preparations), and the monthly analysis report of CDE application acceptance products.
 

4)Patent Service: Patent layout of cooperation projects, patent risk assessment of new products, infringement analysis and circumvention strategies, patent search and analysis service, patent tracking and early warning analysis.

5)Resource sharing: The leadingpharm information department cooperates with many well-known pharmaceutical databases at home and abroad (cortellis, intranet, insight, wisdombud), which can provide domestic and foreign listing information, the latest information on industry policies, new products/targets at home and abroad, domestic and foreign product sales and forecast data, market access, clinical guidelines and clinical front-line drug consultation, etc.


 

 

 

 

 

 

 

麻豆高清免费国产一区| 欧美男男大粗吊1069| 国产97人人超碰cao蜜芽| 欧美激情性做爰免费视频| 国产精品久久欧美久久一区| 欧美精品色婷婷五月综合| 国产乱人对白A片麻豆| 精品无码久久久久久尤物| 天天爽夜夜爽人人爽一区二区 | 欧美成人精品第一区| 亚洲heyzo专区无码综合| 色窝窝免费一区二区三区| 一本色道久久综合亚州精品蜜桃| 国产综合久久久久久精品| 亚洲第一极品精品无码久久| 亚洲 中文字幕 日韩 无码 | 亚洲AV无码片VR一区二区三区| 久久国产精品波多野结衣AV| 天天躁日日躁狠狠躁欧美老妇小说| 免费看男男gay啪啪网站| av中文字幕无码免费看| 国产成人精品一区二三区在线观看| 国产国拍亚洲精品AV在线| 国产乱人对白A片麻豆| 少妇被粗大的猛烈进出a片久久久| 久久99亚洲精品久久久久| 免费观看片的app下载| 亚洲国产成人精品无码区99| 欧美性生交XXXXX无码小说| 99国产精品成人av片免费看| 一本久久a久久精品亚洲| 激情人妻另类人妻伦| 岳叫我弄进去a片免费视频| 久久午夜无码鲁丝片秋霞| 国产最好看的级SUV卡毛| 国产成人亚洲精品无码影院bt| 国产成人精品白浆久久69| 国产精品xxxx国产喷水| 无码人妻熟妇av又粗又大| 豆国产97在线 | 亚洲| 亚洲精品久久久久69影院|